美国大麻股Cronos Group（CRON）今日盘前大涨20.43%，引起市场广泛关注。该股的暴涨与最新传出的政策利好消息密切相关。
据报道，美国前总统特朗普正在考虑将大麻重新归类为低危险药物。这一消息迅速在市场上引发了强烈反响，带动了整个大麻板块的集体上涨。除Cronos Group外，Canopy Growth、Tilray和奥罗拉大麻公司等大麻股也出现了显著涨幅。
《华盛顿邮报》援引知情人士的话称，特朗普在本月初的一场筹款晚宴上透露了这一意向。如果这一调整最终实现，将大大简化大麻的买卖流程，为这个数十亿美元规模的产业带来更多盈利机会。目前，大麻在美国仍被列为一级管制药物，与海洛因等毒品同级。此次潜在的政策变化可能标志着美国大麻行业发展的一个重要转折点，投资者对此反应强烈，推动了Cronos Group等大麻股的大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.